Gabrielle Meyers

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia et al. · Blood Advances · 2020 · 97 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia

Curtis A. Lachowiez, Nicola Long, Jennifer N. Saultz et al. · Blood Advances · 2022 · 92 citations · Full text

Medicine, Hematology, Oncology +13

Next‐generation sequencing‐defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse

Richard D. Press, Garrett Eickelberg, Allison Froman et al. · American Journal of Hematology · 2019 · 73 citations · Full text

Medicine, Hematology, Oncology +17

Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial

Richard T. Maziarz, Timothy Devos, Carlos Bachier et al. · Biology of Blood and Marrow Transplantation · 2014 · 66 citations · Full text

Medicine, Hematology, Immunology +17

Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-versus-Host Disease: Results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802

Shernan G. Holtan, Michael R. Verneris, Kirk R. Schultz et al. · Biology of Blood and Marrow Transplantation · 2015 · 61 citations · Full text

Medicine, Clinical Sciences, Hematology +17